The clinical significance of serum C1q tumor necrosis factor-related protein-9 (CTRP9) in patients with cerebral infarction
10.3760/cma.j.issn.0578-1426.2019.06.010
- VernacularTitle:脑梗死患者血清CTRP9水平的改变及其临床意义
- Author:
Jianli DAI
1
;
Rong LI
;
Haiting LIU
;
Weiming JIAN
;
Liqin HU
Author Information
1. 空军军医大学西京医院老年病科
- Keywords:
Cerebral infarction;
Clq tumor necrosis factor-related protein-9;
TOAST subtypes;
Stages
- From:
Chinese Journal of Internal Medicine
2019;58(6):449-452
- CountryChina
- Language:Chinese
-
Abstract:
To explore the clinical significance of C1q tumor necrosis factor-related protein-9 (CTRP9) in patients with cerebral infarction.Our data showed that the serum CTRP9 was significantly lower than that of control group,especially in patients with large artery atherosclerotic cerebral infarction.CTRP9 was first decreased and even lower from day 4 to day 10,then gradually elevated.Logistic regression analysis suggested that high CTRP9 level was a protective factor for cerebral infarction.Thus,CTRP9 could be a factor for further classification of cerebral infarction and provides a potential option for disease prevention and treatment.
